VESSEL PUNCTURE SITE SWELLING

VESSEL PUNCTURE SITE SWELLING was reported 41 times

These drug classes are most commonly taken by patients reporting VESSEL PUNCTURE SITE SWELLING:

# Drug Count
0 Nonsteroidal Anti-inflammatory Drug [EPC] 5
1 Platelet Aggregation Inhibitor [EPC] 4
2 Corticosteroid [EPC] 3
3 Kinase Inhibitor [EPC] 3
4 Non-Standardized Food Allergenic Extract [EPC] 3
5 Angiotensin 2 Receptor Blocker [EPC] 2
6 Antidote [EPC] 2
7 Antidote for Acetaminophen Overdose [EPC] 2
8 Antimetabolite [EPC] 2
9 Autologous Cellular Immunotherapy [EPC] 2
10 Benzodiazepine [EPC] 2
11 Calcium Channel Blocker [EPC] 2
12 Calcium [EPC] 2
13 Dihydropyridine Calcium Channel Blocker [EPC] 2
14 Expectorant [EPC] 2
15 Factor Xa Inhibitor [EPC] 2
16 Fluoroquinolone Antibacterial [EPC] 2
17 Folate Analog [EPC] 2
18 HMG-CoA Reductase Inhibitor [EPC] 2
19 Interleukin-4 Receptor alpha Antagonist [EPC] 2
20 Mucolytic [EPC] 2
21 Nicotinic Acid [EPC] 2
22 Nucleoside Analog Antiviral [EPC] 2
23 Tumor Necrosis Factor Blocker [EPC] 2
24 Vitamin A [EPC] 2
25 Vitamin B12 [EPC] 2
26 Vitamin C [EPC] 2
27 Vitamin D [EPC] 2
28 alpha-Adrenergic Blocker [EPC] 2
29 beta-Adrenergic Blocker [EPC] 2
30 Atypical Antipsychotic [EPC] 1
31 Central Nervous System Stimulant [EPC] 1
32 Central alpha-2 Adrenergic Agonist [EPC] 1
33 Gadolinium-based Contrast Agent [EPC] 1
34 Histamine-2 Receptor Antagonist [EPC] 1
35 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1
36 Integrin Receptor Antagonist [EPC] 1
37 Interferon alpha [EPC] 1
38 Interleukin-17A Antagonist [EPC] 1
39 Janus Kinase Inhibitor [EPC] 1
40 Leukocyte Growth Factor [EPC] 1
41 Methylxanthine [EPC] 1
42 Nucleoside Metabolic Inhibitor [EPC] 1
43 PCSK9 Inhibitor [EPC] 1
44 Potassium-sparing Diuretic [EPC] 1
45 Progestin [EPC] 1
46 Progestin-containing Intrauterine System [EPC] 1
47 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
48 Pyruvate Kinase Activator [EPC] 1
49 Thalidomide Analog [EPC] 1
50 Thiazide Diuretic [EPC] 1
51 mTOR Inhibitor Immunosuppressant [EPC] 1